Live tape
Top 8, mentions 7d6,143GOOGL1,225 mentions▲ +0.04AAPL1,135 mentions▲ +0.07ORCL860 mentions▲ +0.04META747 mentions▲ +0.05NVDA735 mentions▲ +0.06SPY488 mentions▲ +0.06QQQ480 mentions▲ +0.07TSLA473 mentions▲ +0.07

Equity · Healthcare

ICLR

ICON Public Limited Company · NasdaqGS

$165 +2.48% 1D Finazon · prior-day close · Aug 7, 2026
Price · Chart
Our own end-of-day closes 36 sessions
$200 $140 17 Jun 7 Aug

The line runs $143 on 17 June through $165 on 7 August, on a scale from $140 to $200. Days the market did not trade hold the previous close, flat.

The chart above plots the price of ICLR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 36 sessions over that window: $143 on 17 June 2026 through $165 on 7 August 2026.

52-week range $80 – $203
Avg volume 320.6K

Finazon · prior-day close · as of Sep 14, 2026

ICLR insider trades

SEC Form 4 · last 90 days · newest reported trade 11 Aug 2026
Open-market buys 0
Open-market sells 9
Net sold $1.72M
Non-trade filings 9
Date Insider Type Shares Value
11 Aug 2026 CLIMAX JOHN DR Director Sell 841 $138K
11 Aug 2026 Clerkin Nigel Bernard John Chief Financial Officer Sell 2,267 $372K
11 Aug 2026 Grais Linda Director Sell 841 $138K
11 Aug 2026 McCague Eugene Pacelli Director Sell 841 $138K
11 Aug 2026 Murphy Ronan Martin Director Sell 841 $138K
11 Aug 2026 Murray Ciaran Director Sell 2,677 $440K
11 Aug 2026 O'Neill Julie Director Sell 915 $150K
11 Aug 2026 Whitaker Anne Clem Director Sell 841 $138K
10 Aug 2026 Balfe Barry Edward Chief Executive Officer Sell 382 $63K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
10 Aug 2026 CLIMAX JOHN DR Director Option exercise 1,732
10 Aug 2026 Clerkin Nigel Bernard John Chief Financial Officer Option exercise 4,293
10 Aug 2026 Grais Linda Director Option exercise 1,732
10 Aug 2026 McCague Eugene Pacelli Director Option exercise 1,732
10 Aug 2026 Murphy Ronan Martin Director Option exercise 1,732
10 Aug 2026 Murray Ciaran Director Option exercise 2,677
10 Aug 2026 O'Neill Julie Director Option exercise 1,732
10 Aug 2026 Whitaker Anne Clem Director Option exercise 1,732
07 Aug 2026 Balfe Barry Edward Chief Executive Officer Option exercise 728

ICLR reported financials

SEC EDGAR XBRL

ICLR reported revenue of $8.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $229.3M.

Figure Reported Period
Revenue $8.3B 31 Dec 2025 fiscal year
Net income $229.3M 31 Dec 2025 fiscal year
Diluted EPS $2.90 31 Dec 2025 fiscal year
Total assets $16.3B 31 Dec 2025 at period end
Total equity $9.2B 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

ICLR institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a ICLR position for the quarter ended 30 Jun 2026 — a combined $370.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) +13.2% shares 1,357,143 $235.7M
Point72 Asset Management Added +3,610.3% shares 365,945 $63.6M
Marshall Wace Added +1,121.1% shares 175,440 $30.5M
Citadel Advisors Trimmed −41.0% shares 148,573 $25.8M
Millennium Management Held (±25%) −4.5% shares 48,483 $8.4M
Tudor Investment Corp Trimmed −59.8% shares 26,270 $4.6M
Balyasny Asset Management Trimmed −96.4% shares 4,859 $844K
Renaissance Technologies New position 4,500 $782K

Source: SEC EDGAR 13F filings

ICLR fails-to-deliver

SEC CNS data

On 14 Aug 2026, 3,330 shares of ICLR failed to deliver (about $558K).

Settlement date Shares failed Notional % of shares out
14 Aug 2026 3,330 $558K 0.004%
10 Aug 2026 199 $33K <0.001%
06 Aug 2026 94 $15K <0.001%
04 Aug 2026 512 $81K 0.001%
03 Aug 2026 13,393 $2.2M 0.017%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in ICLR

STOCK Act disclosures

The most recent congressional trade disclosed in ICLR is a sale by Kevin Hern (house, OK), dated 14 Aug 2026.

Date Member Type Amount
14 Aug 2026 filed 01 Sep 2026 Kevin Hern house · Republican–OK Sale $15K–$50K

Source: U.S. House of Representatives financial disclosures